bioAffinity Technologies, Inc. (BIAF) vs Creative Medical Technology Holdings, Inc. (CELZ)

A side-by-side comparison of bioAffinity Technologies, Inc. and Creative Medical Technology Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
bioAffinity Technologies, Inc. logo
BIAF
bioAffinity Technologies, Inc.
$3M
$6.06HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Creative Medical Technology Holdings, Inc. logo
CELZ
Creative Medical Technology Holdings, Inc.
$2M
$0.90HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — BIAF vs CELZ

growth of $100 · dividends reinvested · last 4y
BIAF -99.8% (-79.8%/yr)CELZ -86.6% (-39.5%/yr)CELZ compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $1002023202420252026$0$13
BIAF CELZ

BIAF vs CELZ: by the numbers

  • •BIAF is the larger company ($3M vs $2M market cap).
  • •Both run net losses; BIAF's is the smaller (-257.33% vs -201355.37% net margin).

Metrics side by side

Valuation

MetricBIAFCELZ
P/S ratio0.43774.54
P/B ratio0.670.27

Profitability

MetricBIAFCELZ
Gross margin23.21%63.43%
Operating margin-171.58%-102380.23%
Net margin-257.33%-201355.37%
ROE-402.92%-69.79%
ROIC-237.93%-71.90%

Growth (annualized)

MetricBIAFCELZ
Revenue CAGR (5Y)N/A-50.85%
Total return CAGR (5Y)N/A-57.96%

Go deeper

Full BIAF analysisFull CELZ analysisInteractive comparison tool

Dig into the metrics

bioAffinity Technologies ROECreative Medical Technology ROEbioAffinity Technologies operating marginCreative Medical Technology operating marginbioAffinity Technologies revenue growthCreative Medical Technology revenue growthbioAffinity Technologies free cash flowCreative Medical Technology free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.